AKT1 and cancer: FOXO3a activation induced by the inhibition of PI3K/Akt is involved in cisplatin‐induced cytotoxicity in several cancers such as colorectal, lung and OSCC, suggesting that drugs that deactivate PI3K/Akt could be a promising anticancer therapy.50, 51